Leidos (LDOS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
LDOS is set to report first-quarter results with acquisitions and demand for health services and defense in focus as consensus sees revenues at $4.27 billion and EPS at $2.88.
Leidos (LDOS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Leidos (LDOS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Leidos (LDOS) concluded the recent trading session at $146.06, signifying a -1.04% move from its prior day's close.
Leidos (LDOS) closed at $153.2 in the latest trading session, marking a -1.05% move from the prior day.
In the closing of the recent trading day, Leidos (LDOS) stood at $159.04, denoting a +1.84% move from the preceding trading day.
Leidos (LDOS) closed the most recent trading day at $158.82, moving +1.8% from the previous trading session.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Leidos (LDOS) closed at $162.54 in the latest trading session, marking a -2.01% move from the prior day.
Leidos Holdings, Inc. (LDOS) Presents at JPMorgan Industrials Conference 2026 Transcript
Alliancebernstein L.P. raised its position in Leidos Holdings, Inc. (NYSE: LDOS) by 26.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,926,646 shares of the aerospace company's stock after purchasing an additional 397,385 shares during the quarter. Alliancebernstein L.P. owned about